-
-
-
-
-
-
-
OpGen Enters Into Distribution Agreement for Unyvero in the U.S. with Fisher Healthcare
-
-
-
-
-
-
-
CORRECTION – OpGen Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
-
-
-
-
-
-
OpGen subsidiary Ares Genetics announces granting of key patent in China
-
-
-
-
-
-
-
OpGen (OPGN) Announced 1-for-20 Reverse Stock Split
-
-
-
-
-
-
-
OpGen to Provide Business Update and Financial Results for the Third Quarter 2022 on November 10th at 4:30 p.m. Eastern Standard Time
-
-
-
-
-
-
-
OpGen Announces $3.38 Million Registered Direct Offering
-
-
-
-
-
-
-
OpGen Reports Second Quarter 2022 Financial Results and Provides Business Update
-
1,197,253 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

